任意団体JBCRG学会発表
2013年
Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy: First safety analysis of CREATE-X (JBCRG-04)
Shoichiro Ohtani, Norikazu Masuda, Young-Hyuck Im, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim, Yasuhiro Yanagita, Shintaro Takao, Shinji Ohno, Kenjiro Aogi, Hiroji Iwata, Katsuhide Yoshidome, Reiki Nishimura, Eun Sook Lee, Isao Yokota, Yasuo Ohashi, Soo-Jung Lee, Masakazu Toi
2013 SABCS Poster